These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32643303)

  • 41. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
    Mondillon L; Mermillod M; Musca SC; Rieu I; Vidal T; Chambres P; Auxiette C; Dalens H; Marie Coulangeon L; Jalenques I; Lemaire JJ; Ulla M; Derost P; Marques A; Durif F
    Neuropsychologia; 2012 Oct; 50(12):2869-2879. PubMed ID: 22944002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex.
    Caparros-Lefebvre D; Blond S; Feltin MP; Pollak P; Benabid AL
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):308-14. PubMed ID: 10449551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
    Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
    Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deep brain stimulation of subthalamic nuclei affects arm response inhibition in Parkinson's patients.
    Mirabella G; Iaconelli S; Romanelli P; Modugno N; Lena F; Manfredi M; Cantore G
    Cereb Cortex; 2012 May; 22(5):1124-32. PubMed ID: 21810782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subthalamic nucleus deep brain stimulation on motor-symptoms of Parkinson's disease: Focus on neurochemistry.
    Stefani A; Trendafilov V; Liguori C; Fedele E; Galati S
    Prog Neurobiol; 2017 Apr; 151():157-174. PubMed ID: 28159574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease.
    DeLong MR; Wichmann T
    JAMA Neurol; 2015 Nov; 72(11):1354-60. PubMed ID: 26409114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The subthalamic nucleus influences visuospatial attention in humans.
    Schmalbach B; Günther V; Raethjen J; Wailke S; Falk D; Deuschl G; Witt K
    J Cogn Neurosci; 2014 Mar; 26(3):543-50. PubMed ID: 24144249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compensatory stepping in Parkinson's disease is still a problem after deep brain stimulation randomized to STN or GPi.
    St George RJ; Carlson-Kuhta P; King LA; Burchiel KJ; Horak FB
    J Neurophysiol; 2015 Sep; 114(3):1417-23. PubMed ID: 26108960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep brain stimulation for the treatment of Parkinson's disease.
    Volkmann J
    J Clin Neurophysiol; 2004; 21(1):6-17. PubMed ID: 15097290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease.
    Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC
    Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
    Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
    Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.